Zomato recovers 2% as bullish brokerages hike the target price

Shares of Zomato rose over 2 per cent on the NSE on Wednesday after it tanked two days post the company’s Q4 financial results, although analysts gave thumbs up to its performance. Analysts also expect its weightage in the MSCI EM Index likely to go up after today’s rejig by the global index major that will take effect from May 31.

Shares of Zomato rose over 2 per cent on the NSE on Wednesday after it tanked two days post the company’s Q4 financial results, although analysts gave thumbs up to its performance. Analysts also expect its weightage in the MSCI EM Index likely to go up after today’s rejig by the global index major that will take effect from May 31.

The food delivery aggregator platform had reported a consolidated net profit of ₹175 crore in the March quarter as against a net loss of ₹188 crore in the corresponding period in the previous fiscal.

Also read: Zomato hits 20-month high after delivering strong Q3The company had also disclosed that its subsidiary Zomato Payments Private Ltd has decided to voluntarily surrender the certificate of authorisation issued by RBI to operate as an online payment aggregator. 

Brokerages callMost brokerages, including Nuvama, Jefferies and Nomura , remained positive on the stock and retained their ‘buy’ ratings on Zomato. 

Domestic brokerage Kotak Securities maintained its ‘buy’ rating for the stock but cut the target price to ₹225 from ₹230. 

Emkay Global retained its ‘buy’ rating on the stock with a target price of ₹230 from the earlier ₹170. 

The analysts have increased FY25/FY26E EPS by 41-52 per cent (EBIT by 18-20 per cent) factoring in higher growth. margin assumptions for Blinkit and lower ETR. With better clarity on product-market fit and roadmap to profitability for Blinkit, they added, “we now value it on DCF, compared to 1x FY26E GOV earlier.” 

Analysts of JM Financial have increased GOV/Revenue estimates for Blinkit by 15-41 per cent over FY25/26, which has led to a change in SOTP-driven Mar’25 FV for the Zomato stock to ₹260 from ₹200 earlier. 

Maintaining ‘buy’ call, the brokerage quoted, “We expect Blinkit to double down on growth post break-even at Adj. EBITDA levels by 1QFY25, which should ensure exponential growth for the business in the near to medium term.” It is believed that Blinkit in the long term will command premium profit multiples to Zomato’s own food delivery business as it is relatively more sticky and a play on retail commerce (bigger TAM and longer growth runway). 

Also read: Zomato offers daily payout option for small restaurant playersGlobal brokerage Nomura said that the company’s food delivery business continues to grow steadily. 

UBS maintained its ‘buy’ call on the stock with a target price of ₹250.

Jefferies upped the target price to ₹230 from ₹200 and maintained the ‘buy’ call.  

CLSA, maintaining its ‘buy’ call, set the target price at ₹248. The brokerage highlighted the company’s strong guidance for Blinkit.

Meanwhile, Bernstein maintained its ‘outperform’ rating raising the target price to ₹230 from ₹200. 

The stock ended 2.14 per cent higher on Wednesday’s trade at ₹191.30 on the NSE.

It ended at ₹191.95 on the BSE, higher by 2.40 per cent.

Like (0)
Previous May 15, 2024 4:24 pm
Next May 15, 2024 10:58 pm

Related posts

  • Workday fell more than 12% in pre-market, lowered fiscal 2025 subscription revenue guidance

    Gelonghui, May 24 | Human resources software provider Workday (WDAY.US) U.S. stocks fell 12.23% before the market opened, at $229

    US stock market May 24, 2024
  • Yihua Shares: Net profit in the first quarter of 2024 was 86.6785 million yuan, a year-on-year increase of 456.11%

    CSI Intelligent Financial Information Yihua Co., Ltd. (002897) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 1.529 billion yuan, a year-on-year increase of 63.18%; net profit attributable to the parent company was 86.6785 million yuan, a year-on-year increase of 456.11%; non-net profit after deducting 81.5985 million yuan, a year-on-year increase of 705.72%; generated from operating activities Net cash flow was 6.909 million yuan, compared with -32.6879 million yuan in the same period last year; during the reporting period, Yihua Shares\’ basic earnings per share was 0.51 yuan, and the weighted average return on net assets was 4.89%.

    US stock market April 25, 2024
  • Bonda Asia: U.S. dollar rebounds, oil prices fall, U.S. dollar and Canadian dollar close slightly higher

    On April 25, Quincy Krosby, chief global strategist at LPL Financial, said: “When interest rates start to climb, adjustments have to be made. \”The calculus has changed, so the question is, if interest rates stay higher for longer, will we have a problem?\” ” Recent statements from Fed Chairman Jerome Powell and other policymakers have solidified the view that interest rates will not be cut in the coming months. In fact, there is even talk of another rate hike or two in the future if inflation does not ease further. That leaves many questions: when exactly will monetary policy ease, and what impact will the central bank\’s unchanged stance have on financial markets and the economy as a whole. Krosby said some answers will soon be revealed as the current earnings season heats up. Company executives will provide key details beyond sales and profits, including the impact of interest rates on margins and consumer behavior. He said: \”If there is any indication that businesses are going to have to start cutting costs, causing problems in the job market, then that\’s…

    US stock market April 25, 2024
  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market April 25, 2024
  • New Point Software (688232.SH): Net loss in the first quarter was 52.6446 million yuan

    Gelonghui April 25 | New Point Software (688232.SH) released the first quarter report of 2024. During the reporting period, the company\’s operating income was 294 million yuan, a year-on-year decrease of 14.92%; the net loss attributable to shareholders of the listed company was 52.6446 million yuan; The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 78.7585 million yuan; the basic loss per share was 0.16 yuan/share.

    US stock market April 25, 2024